SK138095A3 - Transdermal therapeutic system for the administration of serotonin agonists - Google Patents

Transdermal therapeutic system for the administration of serotonin agonists Download PDF

Info

Publication number
SK138095A3
SK138095A3 SK1380-95A SK138095A SK138095A3 SK 138095 A3 SK138095 A3 SK 138095A3 SK 138095 A SK138095 A SK 138095A SK 138095 A3 SK138095 A3 SK 138095A3
Authority
SK
Slovakia
Prior art keywords
transdermal therapeutic
therapeutic system
active substances
systemic administration
active
Prior art date
Application number
SK1380-95A
Other languages
English (en)
Slovak (sk)
Inventor
Harald List
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of SK138095A3 publication Critical patent/SK138095A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1380-95A 1993-05-06 1994-04-25 Transdermal therapeutic system for the administration of serotonin agonists SK138095A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4314976A DE4314976C1 (de) 1993-05-06 1993-05-06 Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP1994/001280 WO1994026270A1 (fr) 1993-05-06 1994-04-25 Systemes therapeutiques transdermiques pour l'administration d'agonistes de la serotonine

Publications (1)

Publication Number Publication Date
SK138095A3 true SK138095A3 (en) 1996-06-05

Family

ID=6487316

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1380-95A SK138095A3 (en) 1993-05-06 1994-04-25 Transdermal therapeutic system for the administration of serotonin agonists

Country Status (20)

Country Link
EP (1) EP0697869B1 (fr)
JP (1) JPH08509749A (fr)
KR (1) KR960702306A (fr)
AT (1) ATE183392T1 (fr)
AU (1) AU686159B2 (fr)
CA (1) CA2160776A1 (fr)
CZ (1) CZ289395A3 (fr)
DE (2) DE4314976C1 (fr)
DK (1) DK0697869T3 (fr)
ES (1) ES2138659T3 (fr)
FI (1) FI955260A (fr)
GR (1) GR3031639T3 (fr)
HU (1) HUT74865A (fr)
IL (1) IL109509A (fr)
NO (1) NO954414D0 (fr)
NZ (1) NZ265949A (fr)
PL (1) PL179353B1 (fr)
SK (1) SK138095A3 (fr)
WO (1) WO1994026270A1 (fr)
ZA (1) ZA942872B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510540A (ja) 1994-12-12 1998-10-13 オメロス メディカル システムズ，インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
AU753853B2 (en) * 1999-12-14 2002-10-31 Teikoku Seiyaku Co., Ltd Drugs for relieving hemicrania
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
DK1435945T3 (da) * 2001-06-05 2008-12-01 Ronald Aung-Din Topisk migræne terapi
MXPA05006954A (es) 2002-12-26 2005-09-22 Pozen Inc Formas de dosificacion de capas multiples que contienen nsaids y triptanos.
US20070065463A1 (en) 2003-06-20 2007-03-22 Ronald Aung-Din Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
BRPI0620216A2 (pt) * 2005-12-20 2011-11-01 Teikoku Pharma Usa Inc métodos para administrar transdermicamente um agonista receptor de indol serotonina e composições transdérmicas para uso nos mesmos
CN104138634B (zh) 2006-04-13 2016-09-07 梯瓦制药国际有限责任公司 递送抗偏头痛化合物的透皮方法和系统
US8592424B2 (en) 2008-06-30 2013-11-26 Afgin Pharma Llc Topical regional neuro-affective therapy
CA2775404C (fr) 2009-09-25 2017-01-03 Dr. Reddy's Laboratories Limited Formulations comprenant des composes triptan
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
JP6216151B2 (ja) * 2013-04-19 2017-10-18 コスメディ製薬株式会社 親水性薬物のエマルジョンパッチ
US20160256410A1 (en) 2015-03-02 2016-09-08 Afgin Pharma, Llc Topical regional neuro-affective therapy in mammals with cannabinoids
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
WO1992000103A1 (fr) * 1990-06-28 1992-01-09 Beecham Group Plc Preparations pharmaceutiques
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions

Also Published As

Publication number Publication date
FI955260A0 (fi) 1995-11-02
DK0697869T3 (da) 2000-03-20
IL109509A (en) 1999-12-22
NO954414L (no) 1995-11-03
IL109509A0 (en) 1994-08-26
AU6648094A (en) 1994-12-12
DE4314976C1 (de) 1994-10-06
FI955260A (fi) 1995-11-17
CA2160776A1 (fr) 1994-11-24
WO1994026270A1 (fr) 1994-11-24
HU9503167D0 (en) 1996-01-29
JPH08509749A (ja) 1996-10-15
PL179353B1 (en) 2000-08-31
NZ265949A (en) 1997-10-24
ZA942872B (en) 1995-07-06
AU686159B2 (en) 1998-02-05
KR960702306A (ko) 1996-04-27
NO954414D0 (no) 1995-11-03
HUT74865A (en) 1997-02-28
GR3031639T3 (en) 2000-02-29
PL311591A1 (en) 1996-02-19
DE59408643D1 (de) 1999-09-23
ES2138659T3 (es) 2000-01-16
EP0697869B1 (fr) 1999-08-18
CZ289395A3 (en) 1996-04-17
ATE183392T1 (de) 1999-09-15
EP0697869A1 (fr) 1996-02-28

Similar Documents

Publication Publication Date Title
US5807571A (en) Transdermal therapeutic systems for administering indole serotonin agonists
KR100435611B1 (ko) 에피나스틴을포함하는동통치료용약제학적조성물
US6569866B2 (en) Sustained-release nalmefene preparations and method
US6608073B1 (en) Intranasal codeine for the rapid suppression of cough and rapid relief of pain
SK138095A3 (en) Transdermal therapeutic system for the administration of serotonin agonists
SK2452002A3 (en) A combination of active agents and use thereof
EA200000468A1 (ru) Терапевтическая композиция для введения толтеродина с контролируемым высвобождением
US20050214353A1 (en) Transdermal therapeutic system
RU2002113921A (ru) Препаративные формы гидрокодона с контролируемым высвобождением
EP0404807A1 (fr) Deprenyle pour administration transdermique systemique.
SK284923B6 (sk) Zmes liečiv s antidepresívnym účinkom obsahujúca 2-amino-4,5,6,7- tetrahydro-6-propylaminobenzotiazol a sertralín a jej použitie
US20020010201A1 (en) Method for treating restless leg syndrome using pramipexole and clonidine
CA3156009A1 (fr) Polytherapie avec des antagonistes du cgrp
JP5134973B2 (ja) 医薬の組み合わせでの処置方法およびこれに適する医薬の組み合わせ
SK15652003A3 (sk) Kombinácia účinných látok na medikamentóznu terapiu návykových alebo omamných prostriedkov
IL194500A (en) A peptide substance capable of increasing capillary resistance and pharmacological preparation containing the above
WO2004006929A1 (fr) Composition pour absorption nasale
US4598094A (en) Method and composition for enhancing the effect of indirect-acting sympathomimetic amines
JP2003176227A (ja) 製薬組成物、喫煙を控えている患者の喫煙禁断症状を軽減する方法及び患者の喫煙禁断症状を軽減するキット
RU2192252C2 (ru) Применение прамипексола в лечении синдрома усталых ног
US20010034320A1 (en) NK1-receptor antagonists for treating restless legs syndrome
JP2000500159A (ja) メラトニンと組み合わせた鎮痛剤
CA2547873A1 (fr) Tetrapetpide regulant le taux de sucre sanguin dans le cadre du diabete sucre
US4673689A (en) Method and composition for enhancing the effect of indirect-acting sympathomimetic amines
JPH0788300B2 (ja) エピニンあるいはその製薬的に許容しうる塩を含む医薬組成物ならびに用途